Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2014 09:00 ET | Source: Aurinia Pharmaceuticals

Aurinia Reports Third Quarter 2014 Financial Results

VICTORIA, British Columbia, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH) (TSX:AUP) has released its financial results for the third quarter ended September 30, 2014....
October 21, 2014 08:00 ET | Source: Aurinia Pharmaceuticals

Aurinia Pharmaceuticals to Host Lupus Opinion Leader Meeting and Webcast on October 23 in New York City

VICTORIA, British Columbia, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH) (TSX:AUP) today announced that it will host a Lupus Key Opinion Leader breakfast on Thursday,...
September 02, 2014 08:00 ET | Source: Aurinia Pharmaceuticals

Aurinia Pharmaceuticals to Begin Trading on the NASDAQ Global Market

VICTORIA, B.C., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. (the "Company") (Nasdaq:AUPH) (TSX:AUP) today announced that the Company has received approval by the NASDAQ Listing...
August 14, 2014 16:30 ET | Source: Aurinia Pharmaceuticals

Aurinia Reports Second Quarter 2014 Financial Results

VICTORIA, British Columbia, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. (TSX:AUP) has released its financial results for the second quarter and six months ended June 30, 2014. All...
August 12, 2014 08:00 ET | Source: Aurinia Pharmaceuticals

Aurinia Pharmaceuticals to Present at the Canaccord Genuity 34th Annual Growth Conference

VICTORIA, British Columbia, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals, Inc., (TSX:AUP) today announced that its Chief Operating Officer Michael R. Martin will present a corporate...
July 29, 2014 08:00 ET | Source: Aurinia Pharmaceuticals

Aurinia Adds Financial Expertise to Its Board of Directors

VICTORIA, British Columbia, July 29, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company") (TSX:AUP) today announced that Mr. Charles Rowland Jr. has joined its Board of...
June 26, 2014 08:00 ET | Source: Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Initiates Phase 2b Clinical Trial of Voclosporin to Treat Lupus Nephritis

VICTORIA, British Columbia, June 26, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals, Inc., (TSX-V:AUP) today announced enrollment of the first patient in its planned Phase 2b clinical trial to...
June 23, 2014 08:00 ET | Source: Aurinia Pharmaceuticals

Aurinia to Present at the BIO International Convention

VICTORIA, British Columbia, June 23, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals, Inc., (TSX:AUP) today announced that its Chief Operating Officer, Michael R. Martin, will present a corporate...
June 18, 2014 08:00 ET | Source: Aurinia Pharmaceuticals

Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference

VICTORIA, British Columbia, June 18, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals, Inc., (TSX:AUP) today announced that its President and Chief Executive Officer, Stephen Zaruby, will present a...
June 11, 2014 08:00 ET | Source: Aurinia Pharmaceuticals

Aurinia to Commence Trading on Toronto Stock Exchange

VICTORIA, British Columbia, June 11, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company") (TSX-V:AUP) today announced that its common shares will commence trading on the...